In breast cancer, DCs expressing breast cancer antigens and transfected with siRNA against indoleamine 2,3-dioxygenase have been proven effective in reducing tumor growth and increasing survival in mouse models [159,160]. This evidence concerns the gene IDO2 and breast carcinoma.